← FDA Drug Approvals (Drugs@FDA)

APHEXDA

NDA · New Drug Application · Sponsor: AYRMID PHARMA · Approved 2023-09-08

Drug application

FDA Application #

NDA217159

Application type

New Drug Application

Brand name

APHEXDA

Generic name

MOTIXAFORTIDE

Active ingredients

MOTIXAFORTIDE ACETATE

Dosage form

POWDER

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AYRMID PHARMA

Manufacturer

Gamida Cell Inc.

First approval

2023-09-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown